TLSI · TriSalus Life Sciences, Inc. · Metrics
$4.76
+0.03 (+0.63%)
At close · Sep 9
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our continuation as a going concern is dependent on our ability to generate sufficient cash flows from operations and/or obtain additional capital through equity or debt financings, partnerships, collaborations, strategic alliances and/or licensing arrangements to carry out our long-term business strategy. If we are unable to continue as a going concern, we may have to liquidate our assets and may receive less than fair value for such assets and less than the value at which such assets are carried on our financial statements, and it is likely that investors will lose all or a part of their investment. There can be no assurances that we will be successful in any of these respects, or that we will be able to continue to obtain outside capital in the future or do so on terms that are acceptable to us.”View the 10-Q filed Aug 6, 2026
Market Cap
$307.87M
Shares
61.57M
TLSI metrics
66 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$4.73
Market cap
$307.87M
Price action
20 metricsPrice change (1W)
-8.5%
Price change (30D)
-15.2%
Price change (3M)
+41.6%
Price change (6M)
+11.0%
Price change (YTD)
-32.2%
Price change (1Y)
-5.6%
Trailing year
Price change (5Y)
-52.2%
52-week high
$7.50
52-week low
$2.52
Change from 52-week high
-36.9%
Change from 52-week low
+87.7%
Annualized volatility
79.3%
Annualized volatility (3M)
70.9%
Beta
1.2
RSI (14D)
42.9
Price vs SMA 50
-0.2%
Price vs SMA 200
-2.2%
Avg volume (3M)
291,077
Relative volume
0.4
Average dollar volume
$1.31M
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
61.57M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
6.5×
reciprocal yield 15.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
6.8×
reciprocal yield 14.6%
P / book
47.0
reciprocal yield 2.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-9.2%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-06
Profitability
9 metricsGross margin
85.8%
Operating margin
-67.7%
Trailing 12 months
Net margin
-62.6%
Gross profit (TTM)
$38.67M
Operating profit (TTM)
−$30.51M
Net income (TTM)
−$28.21M
Trailing 12 months
Diluted EPS (TTM)
$-1.31
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+1.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$45.08M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+77.2%
Year over year · more shares
Revenue CAGR (3Y)
+53.9%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-430.7%
Return on assets
-45.2%
Debt / equity
5.0
Current ratio
5.3
EBITDA (TTM)
−$29.95M
Free cash flow (TTM)
—
Quick ratio
5.0
Interest coverage
-5.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$13.22M
Latest balance sheet
Cash & equivalents
$46.29M
Total assets
$62.45M
Total debt
$33.06M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$22.80M
Capital expenditures (TTM)
$480,000
R&D (TTM)
$14.63M
SG&A (TTM)
—
Stock compensation (TTM)
$10.71M
R&D / revenue
32.4%
Stock compensation / revenue
23.8%
Ownership (13F)
3 metrics13F filers
83
13F filer change QoQ
-8
Institutional ownership
37.0%
Short interest
3 metricsShort interest
6.2%
Latest settlement · 14.0 days to cover
Days to cover
14.0d
Short-squeeze score
64 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged
Key facts
CIK
1826667
CUSIP
89680M101
13F (30d)
47 filings
47 filers
Visit website
Investor relations